IL6 and metabolic dysfunction-associated steatotic liver disease: In this study, we identified the downregulation of uc.333 in the livers of db/db mice, HFD-fed mice, IL-6-treated mice, TNF-α-treated mice, and NAFLD patients, indicating that uc.333 may play a key role in IR that is induced by inflammation factors.